Forum on Private Health Insurance categorisation modelling, 25 May 2018, Federal Golf Club, Canberra

This page contains information on the Forum on Private Health Insurance categorisation modelling.

Page last updated: 12 June 2018

Printable version of Private Health Insurance categorisation modelling, 25 May 2018 (PDF 122 KB)


Name Organisation
Dr Rachel David Private Healthcare Australia
Matthew Koce Members Health
Andrew Gale Andrew Gale Consulting
Tory Gervasi Bupa
Ayela Thilo Bupa
Ben Ooi DBN Actuaries
Mario Fortunato HCF
Bruce Beatson Latrobe Health Services
Andrew Matthews Medibank
Damian Ramondetta Navy Health
Dimity Gartzionis nib
Michael Bassingthwaighte Peoplecare
Aaron Newman Queensland Country Health Fund
Brad Joyce Teachers Health
Stuart Rodger Deloitte
Ignatius Li Deloitte
Dr Jeffrey Harmer Chair, Private Health Ministerial Advisory Committee
Susan Azmi Department of Heath
Josh Shanahan Department of Heath
Pierre Nijssen Department of Heath
Kayla Jordan Department of Heath
Alex Caroly Office of the Hon Greg Hunt MP, Minister for Health

1. Overview

  • This forum brought together a selection of actuaries and other representatives from private health insurance funds to consider modelling prepared by Deloitte for the Private Health Ministerial Advisory Committee (PHMAC) on the anticipated impacts of implementing a Gold/Silver/Bronze/Basic categorisation scheme for hospital treatment products.
  • Attendees were asked to consider the Deloitte modelling and comment on its accuracy and indicate whether insurers felt it provided a reliable reflection of the market.

2. Opening remarks

  • The Chair of PHMAC, Dr Harmer indicated that the forum was intended to be a technical discussion on Deloitte’s modelling, rather than a policy discussion on the product design approach formulated by PHMAC.
  • The Department indicated that the details of the product categorisation arrangements, such as allocation of clinical categories to product tiers, had not been finalised. It was noted that the final details for the new product categories would be a decision for the Minister and Government.
  • Attendees were advised that the modelling they had been provided is sensitive and not to be shared with people outside the forum.

3. Issues discussed

  • Deloitte delivered a presentation on the product categorisation modelling undertaken for the PHMAC. The presentation identified the key industry data used to build its model and the methodology and assumptions applied as part of the analysis.
  • The group considered the assumptions and methodology applied by Deloitte in its model and discussed the key findings of the analysis, including the impacts of different product categorisation approaches on premiums and private health insurance participation.
  • The group also discussed the premium impacts of applying changes to the regulation of restrictions.
  • Deloitte also provided results of sensitivity analysis and the modelling of alternative scenarios.

4. Closing remarks

  • Attendees were thanked for their participation in the forum.
  • The Department invited attendees to provide the Department with written feedback on the Deloitte modelling by 1 June 2018.

In this section